<?xml version="1.0" encoding="UTF-8"?>
<drug type="small molecule" created="2005-06-13" updated="2020-01-02">
  <drugbank-id primary="true">DB01875</drugbank-id>
  <drugbank-id>EXPT00599</drugbank-id>
  <name>8-azaxanthine</name>
  <description/>
  <cas-number>1468-26-4</cas-number>
  <unii>97MRZ3ZY2U</unii>
  <average-mass>153.0989</average-mass>
  <monoisotopic-mass>153.028674365</monoisotopic-mass>
  <state>solid</state>
  <groups>
    <group>experimental</group>
  </groups>
  <general-references>
    <articles/>
    <textbooks/>
    <links/>
    <attachments/>
  </general-references>
  <synthesis-reference/>
  <indication/>
  <pharmacodynamics/>
  <mechanism-of-action/>
  <toxicity/>
  <metabolism/>
  <absorption/>
  <half-life/>
  <protein-binding/>
  <route-of-elimination/>
  <volume-of-distribution/>
  <clearance/>
  <classification>
    <description>This compound belongs to the class of organic compounds known as triazolopyrimidines. These are polycyclic aromatic compounds containing triazole ring fused to a pyrimidine ring. Triazole is a five-membered ring consisting of two carbon atoms and three nitrogen atoms. Pyrimidine is a 6-membered ring consisting of four carbon atoms and two nitrogen centers at the 1- and 3- ring positions.</description>
    <direct-parent>Triazolopyrimidines</direct-parent>
    <kingdom>Organic compounds</kingdom>
    <superclass>Organoheterocyclic compounds</superclass>
    <class>Triazolopyrimidines</class>
    <subclass/>
    <alternative-parent>Azacyclic compounds</alternative-parent>
    <alternative-parent>Heteroaromatic compounds</alternative-parent>
    <alternative-parent>Hydrocarbon derivatives</alternative-parent>
    <alternative-parent>Lactams</alternative-parent>
    <alternative-parent>Organic oxides</alternative-parent>
    <alternative-parent>Organonitrogen compounds</alternative-parent>
    <alternative-parent>Organooxygen compounds</alternative-parent>
    <alternative-parent>Organopnictogen compounds</alternative-parent>
    <alternative-parent>Pyrimidones</alternative-parent>
    <alternative-parent>Triazoles</alternative-parent>
    <alternative-parent>Vinylogous amides</alternative-parent>
    <substituent>1,2,3-triazole</substituent>
    <substituent>Aromatic heteropolycyclic compound</substituent>
    <substituent>Azacycle</substituent>
    <substituent>Azole</substituent>
    <substituent>Heteroaromatic compound</substituent>
    <substituent>Hydrocarbon derivative</substituent>
    <substituent>Lactam</substituent>
    <substituent>Organic nitrogen compound</substituent>
    <substituent>Organic oxide</substituent>
    <substituent>Organic oxygen compound</substituent>
    <substituent>Organonitrogen compound</substituent>
    <substituent>Organooxygen compound</substituent>
    <substituent>Organopnictogen compound</substituent>
    <substituent>Pyrimidine</substituent>
    <substituent>Pyrimidone</substituent>
    <substituent>Triazole</substituent>
    <substituent>Triazolopyrimidine</substituent>
    <substituent>Vinylogous amide</substituent>
  </classification>
  <salts/>
  <synonyms>
    <synonym language="english" coder="">Xanthazol</synonym>
  </synonyms>
  <products/>
  <international-brands/>
  <mixtures/>
  <packagers/>
  <manufacturers/>
  <prices/>
  <categories>
    <category>
      <category>Alkaloids</category>
      <mesh-id>D000470</mesh-id>
    </category>
    <category>
      <category>Heterocyclic Compounds, Fused-Ring</category>
      <mesh-id>D000072471</mesh-id>
    </category>
    <category>
      <category>Purines</category>
      <mesh-id>D011687</mesh-id>
    </category>
    <category>
      <category>Purinones</category>
      <mesh-id>D011688</mesh-id>
    </category>
  </categories>
  <affected-organisms/>
  <dosages/>
  <atc-codes/>
  <ahfs-codes/>
  <pdb-entries>
    <pdb-entry>1j2g</pdb-entry>
    <pdb-entry>1r51</pdb-entry>
    <pdb-entry>1vay</pdb-entry>
    <pdb-entry>2fub</pdb-entry>
    <pdb-entry>2h0f</pdb-entry>
    <pdb-entry>2iba</pdb-entry>
    <pdb-entry>2ic0</pdb-entry>
    <pdb-entry>2icq</pdb-entry>
    <pdb-entry>2pes</pdb-entry>
    <pdb-entry>2yzd</pdb-entry>
    <pdb-entry>2zka</pdb-entry>
    <pdb-entry>2zkb</pdb-entry>
    <pdb-entry>3bk8</pdb-entry>
    <pdb-entry>3cks</pdb-entry>
    <pdb-entry>3cku</pdb-entry>
    <pdb-entry>3f2m</pdb-entry>
    <pdb-entry>3gko</pdb-entry>
    <pdb-entry>3p9f</pdb-entry>
    <pdb-entry>3pjk</pdb-entry>
    <pdb-entry>3pk3</pdb-entry>
    <pdb-entry>3pk4</pdb-entry>
    <pdb-entry>3pk5</pdb-entry>
    <pdb-entry>3pk6</pdb-entry>
    <pdb-entry>3pk8</pdb-entry>
    <pdb-entry>3pkf</pdb-entry>
    <pdb-entry>3pkg</pdb-entry>
    <pdb-entry>3pkh</pdb-entry>
    <pdb-entry>3pkk</pdb-entry>
    <pdb-entry>3pkl</pdb-entry>
    <pdb-entry>3pks</pdb-entry>
    <pdb-entry>3pkt</pdb-entry>
    <pdb-entry>3pku</pdb-entry>
    <pdb-entry>3ple</pdb-entry>
    <pdb-entry>3plg</pdb-entry>
    <pdb-entry>3plh</pdb-entry>
    <pdb-entry>3pli</pdb-entry>
    <pdb-entry>3plj</pdb-entry>
    <pdb-entry>3plm</pdb-entry>
    <pdb-entry>3wlv</pdb-entry>
    <pdb-entry>4n3m</pdb-entry>
    <pdb-entry>4n9v</pdb-entry>
    <pdb-entry>4op6</pdb-entry>
    <pdb-entry>4op9</pdb-entry>
    <pdb-entry>4xfp</pdb-entry>
    <pdb-entry>5frc</pdb-entry>
    <pdb-entry>5utj</pdb-entry>
    <pdb-entry>5y2p</pdb-entry>
    <pdb-entry>5y52</pdb-entry>
    <pdb-entry>5yj2</pdb-entry>
    <pdb-entry>5yja</pdb-entry>
    <pdb-entry>5z27</pdb-entry>
    <pdb-entry>5z29</pdb-entry>
    <pdb-entry>5z2a</pdb-entry>
    <pdb-entry>5z2b</pdb-entry>
    <pdb-entry>6i9x</pdb-entry>
    <pdb-entry>6i9z</pdb-entry>
    <pdb-entry>6ia1</pdb-entry>
    <pdb-entry>6ia3</pdb-entry>
    <pdb-entry>6ia9</pdb-entry>
    <pdb-entry>6ic1</pdb-entry>
  </pdb-entries>
  <patents/>
  <food-interactions/>
  <drug-interactions/>
  <calculated-properties>
    <property>
      <kind>logP</kind>
      <value>-0.17</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>IUPAC Name</kind>
      <value>1H,4H,5H,6H,7H-[1,2,3]triazolo[4,5-d]pyrimidine-5,7-dione</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Traditional IUPAC Name</kind>
      <value>4-[(2S)-2-{[(3S)-1-{[1,1'-biphenyl]-4-ylmethyl}-2-oxoazepan-3-yl]carbamoyl}-2-acetamidoethyl]-2-phosphonophenoxyacetic acid</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Weight</kind>
      <value>153.0989</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Monoisotopic Weight</kind>
      <value>153.028674365</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>SMILES</kind>
      <value>O=C1NC2=C(NN=N2)C(=O)N1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Formula</kind>
      <value>C4H3N5O2</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChI</kind>
      <value>InChI=1S/C4H3N5O2/c10-3-1-2(8-9-7-1)5-4(11)6-3/h(H3,5,6,7,8,9,10,11)</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChIKey</kind>
      <value>KVGVQTOQSNJTJI-UHFFFAOYSA-N</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polar Surface Area (PSA)</kind>
      <value>99.77</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Refractivity</kind>
      <value>36.01</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polarizability</kind>
      <value>11.9</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rotatable Bond Count</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Acceptor Count</kind>
      <value>4</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Donor Count</kind>
      <value>3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest acidic)</kind>
      <value>5.17</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest basic)</kind>
      <value>-3.1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Physiological Charge</kind>
      <value>-1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Number of Rings</kind>
      <value>2</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Bioavailability</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rule of Five</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Ghose Filter</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>MDDR-Like Rule</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
  </calculated-properties>
  <experimental-properties/>
  <external-identifiers>
    <external-identifier>
      <resource>ChEBI</resource>
      <identifier>40850</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Compound</resource>
      <identifier>15113</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Substance</resource>
      <identifier>46508460</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChemSpider</resource>
      <identifier>14385</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PDB</resource>
      <identifier>AZA</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEMBL</resource>
      <identifier>CHEMBL219341</identifier>
    </external-identifier>
  </external-identifiers>
  <external-links/>
  <pathways/>
  <reactions/>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets>
    <target>
      <id>BE0001313</id>
      <name>Uric acid degradation bifunctional protein</name>
      <organism>Bacillus sp. (strain TB-90)</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <ref-id>A1713</ref-id>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <ref-id>A1715</ref-id>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q45697" source="Swiss-Prot">
        <name>Uric acid degradation bifunctional protein</name>
        <general-function>Urate oxidase activity</general-function>
        <specific-function>Catalyzes two steps in the degradation of uric acid, i.e. the oxidation of uric acid to 5-hydroxyisourate (HIU) and the stereoselective decarboxylation of 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline (OHCU) to (S)-allantoin (By similarity).</specific-function>
        <gene-name>uao</gene-name>
        <locus/>
        <cellular-location/>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>6.58</theoretical-pi>
        <molecular-weight>57977.435</molecular-weight>
        <chromosome-location/>
        <organism ncbi-taxonomy-id="36824">Bacillus sp. (strain TB-90)</organism>
        <external-identifiers>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>AB048366</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>12082301</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>Q45697</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>PUCL_BACSB</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>4.1.1.97</synonym>
          <synonym>OHCU decarboxylase</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0002608|Uric acid degradation bifunctional protein
MMRLKQLNEMSASEFIHLLGGVFENSSWVAERAEPNRPYSSFQSLYNKMVEIVETASDNE
QLKLIQMHPHLGTNVKITDFSQEEQKHAGLNELTKDEQNHLILLNQKYKDKFGFPFVMAV
RGKIKQEIFRTIKERLQNNHQTEFKQALEEIKKIAMFRLQEIFREGENNSMTKHKERVMY
YGKGDVFAYRTYLKPLTGVRTIPESPFSGRDHILFGVNVKISVGGTKLLTSFTKGDNSLV
VATDSMKNFIQKHLASYTGTTIEGFLEYVATSFLKKYSHIEKISLIGEEIPFETTFAVKN
GNRAASELVFKKSRNEYATAYLNMVRNEDNTLNITEQQSGLAGLQLIKVSGNSFVGFIRD
EYTTLPEDSNRPLFVYLNIKWKYKNTEDSFGTNPENYVAAEQIRDIATSVFHETETLSIQ
HLIYLIGRRILERFPQLQEVYFESQNHTWDKIVEEIPESEGKVYTEPRPPYGFQCFTVTQ
EDLPHENILMFSDEPDHKGALK</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0002607|1509 bp
ATGATGCGATTAAAACAATTAAATGAAATGAGTGCTTCCGAATTTATCCATCTATTAGGA
GGAGTTTTTGAGAATTCATCATGGGTGGCCGAACGAGCAGAACCCAATCGCCCATACTCT
TCCTTTCAATCTCTATATAATAAAATGGTGGAGATTGTCGAAACCGCTTCGGATAACGAA
CAATTAAAATTAATTCAAATGCATCCGCATCTAGGCACCAACGTCAAAATAACCGATTTC
TCTCAAGAGGAACAGAAACATGCCGGATTAAATGAATTAACAAAAGATGAACAGAATCAT
CTCATTTTACTCAACCAAAAATACAAGGATAAATTTGGATTTCCATTTGTAATGGCCGTT
CGAGGAAAAATCAAACAAGAAATTTTTAGAACGATCAAAGAACGATTACAAAATAATCAT
CAAACGGAGTTTAAACAAGCATTGGAAGAAATTAAAAAAATCGCAATGTTTCGTTTGCAA
GAAATATTTCGTGAAGGAGAGAATAATTCGATGACCAAACACAAAGAAAGAGTGATGTAT
TATGGAAAAGGTGACGTATTTGCTTATCGCACCTATTTAAAACCACTTACTGGAGTTAGA
ACGATTCCTGAATCTCCATTTTCCGGTCGAGATCATATTCTTTTTGGAGTAAATGTAAAA
ATCTCAGTAGGAGGAACAAAATTGCTGACCTCCTTTACGAAAGGGGATAACAGCTTAGTC
GTTGCAACAGACTCGATGAAAAACTTTATACAAAAACATTTAGCTAGTTATACAGGAACA
ACGATAGAAGGTTTTTTAGAATATGTAGCTACTTCTTTTTTGAAGAAATATTCTCATATT
GAAAAGATTTCGTTGATAGGAGAGGAAATTCCCTTTGAAACAACTTTTGCAGTAAAGAAT
GGAAATAGAGCAGCTAGTGAGCTAGTATTTAAAAAATCACGAAATGAATATGCCACCGCT
TATTTGAATATGGTTCGTAATGAAGATAACACCCTAAACATTACTGAACAACAAAGCGGA
CTTGCTGGTCTTCAATTAATAAAAGTCAGCGGAAATTCCTTTGTCGGTTTTATTCGTGAC
GAATACACAACTCTTCCAGAGGATTCAAACCGCCCTCTATTTGTTTACTTAAACATCAAA
TGGAAGTACAAAAACACGGAAGACTCATTTGGAACGAATCCAGAAAATTATGTTGCAGCT
GAACAAATTCGCGACATCGCCACTTCCGTATTTCATGAAACCGAGACGCTTTCCATCCAA
CATTTAATTTATTTAATCGGCCGCAGAATATTAGAAAGATTCCCTCAACTTCAAGAAGTT
TACTTCGAATCTCAAAATCATACATGGGATAAAATAGTGGAGGAAATTCCTGAATCAGAA
GGGAAAGTATATACAGAACCGCGACCGCCATATGGATTTCAATGCTTTACTGTCACCCAA
GAAGACTTGCCACACGAAAACATTCTTATGTTCTCTGATGAACCCGATCATAAAGGAGCA
CTTAAATGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF01014</identifier>
            <name>Uricase</name>
          </pfam>
          <pfam>
            <identifier>PF09349</identifier>
            <name>OHCU_decarbox</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>function</category>
            <description>carboxy-lyase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>urate oxidase activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>allantoin biosynthetic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>purine nucleobase metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>urate catabolic process</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
  </targets>
  <enzymes/>
  <carriers/>
  <transporters/>
</drug>